WO2003015701A9 - Lipobeads and their production - Google Patents
Lipobeads and their productionInfo
- Publication number
- WO2003015701A9 WO2003015701A9 PCT/US2002/026056 US0226056W WO03015701A9 WO 2003015701 A9 WO2003015701 A9 WO 2003015701A9 US 0226056 W US0226056 W US 0226056W WO 03015701 A9 WO03015701 A9 WO 03015701A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- glycero
- poly
- phosphatidylcholine
- lipobeads
- approximately
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
- Y10T428/2985—Solid-walled microcapsule from synthetic polymer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
- Y10T428/2985—Solid-walled microcapsule from synthetic polymer
- Y10T428/2987—Addition polymer from unsaturated monomers only
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2989—Microcapsule with solid core [includes liposome]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2991—Coated
Definitions
- the present invention concerns nanogels encapsulated within a lipid bilayer (lipobeads) and their production.
- Liposomes are phospholipid assemblies consisting of a flexible, cell membrane- like lipid bilayer, the surface of which acts as a permeability barrier. Different compounds can be entrapped in the liposome's aqueous interior. It has been shown that liposomes can be constructed with bilayer permeability responsive to a variety of physical and chemical stimuli, including temperature, light, pH, and ions (See, e.g., G. Gregoriadis et al, Vesicles, Marcel Dekker: New York (1996). This book is incorporated herein by reference.). These liposomes can mimic various functions of biological membranes and can be used as a container for storage, transport, and controllable release of compounds. Liposomes can be mechanically unstable, however and their loading capacity is limited by the water solubility of the material to be loaded.
- Hydrogel particles are mechanically more stable than liposomes because of cross-linking and have larger loading capacities than liposomes. Their properties (swelling/de-swelling) can be more sensitive to environmental conditions. It has been reported that some polymer gels can swell or shrink discontinuously and reversibly in response to many different stimuli (temperature, pH, ions, electric fields or light) depending on the chemical composition of the gel/solvent system. The volume change can be as large as a thousand-fold. Macroscopic gels respond to the environmental changes on a rather long-time scale, however. (See, e.g., the article Tanaka et al., J. Chem. Phys.. 90: 5161 (1989).
- hydrogels lack many useful surface properties of a lipid bilayer.
- Lipid bilayers stabilized on various supports (glass, plastic, metal, and modified polymer) (See, e.g., the articles: Bayer et al., Biophvs. J. 58: 357 (1990); Rothe et al., FEBS. Lett. 263: 308 (1990); Plant, Lanemuir. 9: 2764 (1993); Spinke et al., Biophvs. J. 63: 1667 (1992). These articles are incorporated herein by reference.) have found a number of applications (See, e.g., the articles: Sackman, Science. 271: 43 (1996); McConnell et al., Biochim.
- hydrogel-liposome assemblies combine the properties of both classes of materials, which broaden their potentials for biomimetic sensory systems, controlled release devices, and multivalent receptors.
- This system contained (i) a hydrogel polymer core anchored by fatty acids, which were covalently attached to the surface of the hydrogel and (ii) a lipid monolayer around the modified hydrogel spherical particle.
- the bilayer consisting of hydrophobic chains of fatty acids and hydrophobic tails of the phospholipids, was more stable than that in the system discussed in the Gao article.
- Spherical anionic microgels (6.5 ⁇ m at pH 7.0), composed of methylene-b/s-acrylamide and methacrylic acid and loaded with doxorubicin, were coated with a lipid bilayer (See Kiser et al., Nature, 394: 459 (1998).
- hydrogel/liposome systems that can respond to changes in the environment on a short time scale are needed.
- the present invention describes preparing and characterizing hydrogel nanoparticles (nanogels) and liposomes.
- the present invention also describes different assemblies of nanogels and liposomes defining various hydrogel/liposome systems. These hydrogel/liposome systems will often combine complementary advantages of the liposomes and the polymeric hydrogels. Studying the individual behavior of the hydrogel particles and liposomes in aqueous solution affords better understanding of the behavior of the hydrogel/liposome system.
- the following systems were prepared and characterized: (i) an unanchored nanogel entrapped in a liposome; (ii) an anchored nanogel entrapped in a liposome; (iii) an aggregate of unanchored nanogels coated with phospholipid bilayer ("giant" lipobeads), (iv) an aggregate of anchored nanogels coated with phospholipid bilayer ("giant” lipobeads), (v) an aggregate of anchored and unanchored nanogels coated with phospholipid bilayer (combined giant lipobeads) and (vi) an aggregate of anchored lipobeads.
- the present invention also describes the size distribution changes of the hydrogel particles, liposomes, and their assemblies in response to solvent variations, temperature variations, pH variations, and ionic strength variations.
- Figure 1 is a scheme depicting lipobead preparation by polymerizing hydrogel-forming components within liposomes.
- Figure 2 is a scheme depicting lipobead preparation by constructing liposomes and nanogels independently and then mixing them together.
- Figure 3 shows graphs of the size distribution curves for (a) liposomes, (b) pure PNTPA nanogels, and their mixture below (c) and above (d) the volume phase transition temperature.
- Figure 4 shows graphs of the size distribution curves for (a) liposomes, (b) anchored PNTPA- VI nanogels, and their mixture (c) below and (d) above the volume phase transition temperature.
- AFM Atomic Force Microscopy
- Figures 6a and 6b are AFM images (amplitude data) of (a) a PNTPA- VI lipobead after gelation inside liposomes (frame 400x400 nm 2 ; 1, flattened lipid bilayer; 2, nanogel); and (b) mixed phospholipid/detergent micelles and a nanogel after lipid bilayer solubilization (frame 440x440 nm 2 ; 1, nanogel; 2, mixed micelles).
- Figure 7 shows graphs of the size distribution curves for (a) PNIPA-VI lipobeads in buffer (pH 7.5) and after addition of 15 mM T x . ⁇ 00 at (b) pH 7.5 and (c) pH 2.5.
- Figure 8 shows a graph of the size distribution curve for PAAm lipobeads in buffer.
- Figures 9a and 9b are (a) an AFM images (amplitude data) of giant lipobeads produced by long-term aging of a mixture of EPC liposomes and PNIPA-VI nanogels after three months (frame 10x10 ⁇ m 2 ) and (b) a schematic presentation of the giant lipobeads formation in aging.
- Figure 10 shows graphs of (a) the Z-average diameter of liposomes as a function of temperature during heating/cooling cycles and (b) pH Dependence of the average diameter of the liposomes.
- Figure 11 shows graphs of the size distribution curves for the pure PNTPA hydrogel particles in water (a) below and (b) above the volume phase transition temperature.
- Figure 12 shows graphs of the size distribution curves for (a) PNTPA lipobeads in buffer at 25 °C, (b) after addition of 15 mM T x . 100 at 25 °C, (c) at 35 °C, and (d) at 40 °C.
- Figure 13 is a table that lists the composition of hydrogel-forming media and properties of macroscopic hydrogels.
- Figure 14 is a graph of the Z-average diameter of anchored PNIPA-VI lipobeads (a) as a function of temperature upon heating/cooling cycles and (b) as a function of pH.
- Figure 15 includes graphs showing the effect of temperature on the collapse and subsequent aggregation of PNIPA-VI nanogels for pure PNIPA-VI nanogels in water at temperatures below, and at a temperature above, the volume phase transition temperature.
- Figure 16 is a graph showing the pH dependence of the average diameter of PNIPA-VI nanogels.
- the present invention concerns lipobeads, giant lipobeads, their production, and their properties.
- the present invention functions to produce assemblies of liposome-encapsulated nanogel particles that respond to environmental conditions such as pH, temperature, and ions on a fast time scale.
- Liposome preparation is described in U.S. Patent Application Serial No. , filed on August 14, 2002, entitled NANOGELS AND THEIR PRODUCTION USING LIPOSOMES AS REACTORS, by Sergey Kazakov, Marian Kaholek, and Kalle Levon (This patent is incorporated herein by reference).
- this technique of preparing liposomes involves freezing and thawing a solution of multilamellar vesicles (MLV) followed by sonication to yield large unilamellar vesicles (LUV) within the range of average sizes from 30 to 1000 nm.
- MLV multilamellar vesicles
- LUV large unilamellar vesicles
- this technique of preparing nanogels involves (i) encapsulating hydrogel-forming components into the liposomes and (ii) polymerizing the encapsulated hydrogel-forming components.
- the present invention may be used to produce lipobeads by (a) polymerizing hydrogel- forming components within liposomes, or (b) mixing nanogel particles with liposomes to form lipid bilayer-coated hydrogel particles.
- the first method prepares liposomes before gelation and then polymerizes hydrogel-forming components inside the liposomes, as shown in Figure 1.
- This method has the advantage of forming a more stable lipid bilayer.
- nanogels inside the liposomes are unable to undergo further modifying treatments such as loading, entrapment, or surface functionalization. Such procedures should be planned in the course of gelation instead.
- Lipobead fusion and formation of "giant" or combined lipobeads is impossible using this method. Polymerizing anchored or unanchored hydrogel-forming components within liposomes was described in U.S. Patent Application Serial No. , filed on August 14, 2002, entitled
- the second method prepares liposomes and nanogels independently, as shown in Figure 2.
- penetration by a nanogel into a liposome ruptures the liposome's lipid bilayer.
- the lipid bilayer on the surface of nanogels is strong and stable enough to mask the nanogels' sensitivity to changes in external conditions.
- the sensitivity of PNIPA-VI lipobeads to temperature and pH was masked due to their lipid bilayer coat (See Figure 11).
- the advantage of fabricating liposomes and nanogels independently is that nanogels can be loaded with different compartments, filled with different liquid media, or/and functionalized with specific ligands before they are coated by a lipid bilayer. Using this method, lipobeads may fuse to form giant lipobeads.
- lipobeads may be prepared by adding a liposome suspension to a solution of unanchored or anchored hydrogel particles. Incubating this solution for 1 to 4 hours at a temperature above the phase transition temperature of the phospholipid (Phospholipids' phase transition temperatures typically range from approximately -16 to +74 °C.
- Phospholipids' phase transition temperatures typically range from approximately -16 to +74 °C.
- unanchored poly(N- isopropylacrylamide) (PNTPA) hydrogel particles formed from 5-10 wt. % hydrogel-forming components
- liposomes formed from 5-10 mg/mL phospholipid in water or buffer
- Figures 3a and 3b show the size distribution curves for the pure liposomes and pure PNTPA nanogels with approximately the same average diameter of approximately 180 nm. Adding liposomes to the suspension of pure PNTPA nanogels and observing the sizes of the resulting structures allows one to determine if lipobeads form or if the particles remain separated. If both particles existed independently without interactions, one could expect that upon increasing temperature the hydrogel particles would shrink, whereas liposomal sizes would not change, and two separate peaks would be detected. If both particles formed aggregates, however, the resulting particles should be at least twice their initial average size, as was seen in Figures 14d and 13b.
- anchored PNTPA- VI lipobeads were generated by mixing PNIPA-VI nanogels (formed from 5-15 wt. % hydrogel-forming components) with liposomes (formed from 5-10 mg/mL phospholipid in water or buffer) in a 1 : 1 ratio, incubating the mixture for 2 hours at room temperature and vortexing.
- FIGs 4a and 4b show the size distribution curves for liposomes and pure anchored PNTPA- VI nanogels with average diameters of approximately 160 nm, as was seen with PNTPA nanogels and liposomes (See Figure 3). Mixing the liposomes and the anchored PNIPA-VI nanogels resulted in lipobeads with the size distribution curve shown in Figure 4c. These three curves imply that the size distribution of the lipobeads is determined by the size distribution of the nanogels. Similar to mixing unanchored PNTPA nanogels and liposomes, each anchored PNTPA- VI hydrogel particle (1) is coated with a liposomes' phospholipid bilayer (2), forming a lipobead during mixing, as shown in Figure 5.
- PAAm poly(acrylamide) hydrogels
- Figure 8 shows a typical particle size distribution and structure of the lipobeads obtained after polymerization within liposomal microreactors.
- “Giant” lipobeads may be produced when lipobeads aggregate quickly due to collapsing the hydrogel particles or slowly due to long-term aging (See Figure 2). Combining liposomes with hydrogel particles to form lipobeads and providing the environmental conditions under which the hydrogel particles collapse and the lipobeads aggregate together produces giant lipobeads. Collapsing unanchored lipobeads and incubating for 1 to 4 hours at a temperature exceeding the volume phase transition temperature of the polymer results in the formation of lipid bilayer-coated hydrogel aggregates, or giant lipobeads.
- Anchored nanogels also may shrink inside liposomes due to temperatures above T v and partially aggregate, but the hydrophobic chains (anchors) on their surface stabilize the lipid bilayer and prevent fusion, thus prohibiting giant lipobeads from forming.
- lipobeads with anchored or unanchored nanogels may form giant lipobeads after long-term aging (2-3 months) at a temperature below the volume phase transition temperature of the polymer. (Lipobeads remain stable for approximately 1 month because the hydrogel stabilizes the lipid bilayer.) This method of producing giant lipobeads does not involve shrinking the nanogels inside the lipobeads.
- unanchored hydrogel particles are mixed with liposomes.
- PNTPA and PNIPA-VI lipobeads aggregate and form giant lipobeads at room temperature (i.e., below volume phase transition temperature) without shrinking the nanogels inside the lipobeads. Aggregation and giant lipobeads formation occur over the course of long-term aging (2-3 months) of the lipobeads.
- An AFM image (amplitude data) of anchored PNTPA- VI giant lipobeads after three months storage at +4 °C is presented in Figure 9. ⁇ 4.2 PROPERTIES OF SYSTEMS GENERATED
- One goal of the present invention is to produce a system that mimics biological entities and responds quickly to changes in environmental conditions such as pH, ions, and temperature.
- Properties of liposomes and nanogels are described in ⁇ 4.2.1 and ⁇ 4.2.2, respectively.
- Properties of lipobeads and giant lipobeads are described in ⁇ 4.2.3 and ⁇ 4.2.4, respectively.
- FIG 10b shows the pH independence of the apparent diameter of EPC liposomes.
- liposomes were prepared at pH 7.5 (initial point, X); pH was increased by addition of 0.2 M NaOH (open circles) and decreased by addition of 0.1 M HCl (solid circles).
- EPC is a neutral phospholipid
- pH-responsive fusion of its lipid bilayer is not expected.
- DLS revealed a tendency of liposomes to aggregate at low pH (pH ⁇ 3), a result ascribed to possible protonation and neutralization of the P " - N* dipole in phosphocholine on the liposome interface and/or to destruction of the hydration shell including interfacial water molecules in close contact with lipid polar head-groups.
- PNTPA PolyfN-isopropylacrylamide
- PNTPA- VI poly(N-isopropylacrylamide-co-l- vinylimidazole) nanogels were characterized in terms of their response to changes in environmental conditions.
- properties of PNTPA and PNIPA-VI nanogels are described in ⁇ 4.2.2.1 and ⁇ 4.2.2.2, respectively.
- the estimated swelling ratio of ⁇ » 4.6 demonstrates the pH-sensitivity of the prepared PNIPA-VI nanogels.
- Lipobeads combine the properties of liposomes and the nanogels they enclose to create a system that is sensitive to changes in environmental conditions.
- unanchored PNTPA lipobeads are described in ⁇ 4.2.3.1 and anchored PNIPA-VI lipobeads are described in ⁇ 4.2.3.2.
- PNTPA lipobeads were prepared as described in ⁇ 4.1.3.
- Figure 12a shows that a relatively broad size distribution of PNTPA lipobeads with a peak at around 250 nm are obtained after UV exposure of a diluted LUV suspension containing initial components of PNTPA gels (See Figure 13, line 3).
- Figure 12b demonstrates that again, addition of T . ⁇ oo in a molar ratio of 45:1 (detergent/lipid) results in two peaks with maxima at 9 nm and 250 nm ascribed to the mixed detergent-phospholipid micelles and the PNTPA hydrogel particles, respectively. The ratio between scattering intensities of small and large particles indicates that the concentration of nanogels is relatively low.
- the present invention can be used to produce lipobeads. Since such assemblies combine the properties of nanogels and liposomes, the present invention provides a system that can respond quickly to environmental changes and therefore opens up many new potential applications for lipobeads.
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002329761A AU2002329761A1 (en) | 2001-08-16 | 2002-08-15 | Lipobeads and their production |
EP02766006.7A EP1511580B1 (en) | 2001-08-16 | 2002-08-15 | Method for producing an anchored lipobead defined by a hydrogel |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31287801P | 2001-08-16 | 2001-08-16 | |
US60/312,878 | 2001-08-16 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2003015701A2 WO2003015701A2 (en) | 2003-02-27 |
WO2003015701A9 true WO2003015701A9 (en) | 2003-04-24 |
WO2003015701A3 WO2003015701A3 (en) | 2004-12-29 |
Family
ID=23213406
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/026055 WO2003015936A1 (en) | 2001-08-16 | 2002-08-15 | Nanogels and their production using liposomes as reactors |
PCT/US2002/026056 WO2003015701A2 (en) | 2001-08-16 | 2002-08-15 | Lipobeads and their production |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/026055 WO2003015936A1 (en) | 2001-08-16 | 2002-08-15 | Nanogels and their production using liposomes as reactors |
Country Status (6)
Country | Link |
---|---|
US (3) | US7943067B2 (en) |
EP (2) | EP1511580B1 (en) |
AT (1) | ATE433744T1 (en) |
AU (1) | AU2002329761A1 (en) |
DE (1) | DE60232666D1 (en) |
WO (2) | WO2003015936A1 (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7943067B2 (en) * | 2001-08-16 | 2011-05-17 | Polytechnic Institute Of New York University | Nanogels and their production using liposomes as reactors |
US20040005352A1 (en) * | 2002-04-16 | 2004-01-08 | Lopez Gabriel P. | Biologically functionalized porous microspheres |
US20040151691A1 (en) * | 2003-01-30 | 2004-08-05 | Oxman Joel D. | Hardenable thermally responsive compositions |
US7223826B2 (en) * | 2003-01-30 | 2007-05-29 | 3M Innovative Properties Company | Amide-functional polymers, compositions, and methods |
US20040185013A1 (en) * | 2003-01-30 | 2004-09-23 | Burgio Paul A. | Dental whitening compositions and methods |
ATE541596T1 (en) * | 2003-04-10 | 2012-02-15 | Teijin Ltd | BIODEGRADABLE FILM WITH HONEYCOMB STRUCTURE |
US9233846B2 (en) * | 2005-10-14 | 2016-01-12 | The Regents Of The University Of California | Formation and encapsulation of molecular bilayer and monolayer membranes |
DE102006015271A1 (en) * | 2006-04-01 | 2007-10-11 | Lohmann & Rauscher Gmbh & Co. Kg | Biguanide-containing liposomes |
WO2009021052A1 (en) * | 2007-08-06 | 2009-02-12 | University Of Kentucky Research Foundation | Polypeptides, systems, and methods useful for detecting glucose |
US7959861B2 (en) * | 2007-09-19 | 2011-06-14 | Stc.Unm | Integrated affinity microcolumns and affinity capillary electrophoresis |
WO2009126442A1 (en) * | 2008-04-10 | 2009-10-15 | Board Of Regents, The University Of Texas System | Compositions and methods for composite nanoparticle hydrogels |
US9445975B2 (en) * | 2008-10-03 | 2016-09-20 | Access Business Group International, Llc | Composition and method for preparing stable unilamellar liposomal suspension |
EP2408848B1 (en) * | 2009-03-16 | 2014-06-25 | Dow Global Technologies LLC | A dispersion, and a process for producing the same |
WO2011103143A1 (en) | 2010-02-16 | 2011-08-25 | The University Of North Carolina At Chapel Hill | Array of micromolded structures for sorting adherent cells |
US9849089B2 (en) * | 2010-10-14 | 2017-12-26 | Amorepacific Corporation | Hydrogel particle coated with lipid and method for manufacturing same |
EP2578207A3 (en) | 2011-10-05 | 2015-10-07 | Jacob J. Schmidt | Masking apertures enabling automation and solution exchange in sessile droplet lipid bilayers |
GB201119032D0 (en) | 2011-11-03 | 2011-12-14 | Isis Innovation | Multisomes: encapsulated droplet networks |
US9603800B2 (en) * | 2012-04-12 | 2017-03-28 | Yale University | Methods of treating inflammatory and autoimmune diseases and disorders using nanolipogels |
FR2993891B1 (en) * | 2012-07-27 | 2016-11-18 | Rhodia Operations | POLYMER COMPOSITION FOR INHIBITING THE FORMATION OF INORGANIC AND / OR ORGANIC DEPOSITS IN UNDERGROUND FORMATIONS |
GB201219201D0 (en) | 2012-10-25 | 2012-12-12 | Isis Innovation | Hydrogel network |
GB201219196D0 (en) | 2012-10-25 | 2012-12-12 | Isis Innovation | Droplet assembly method |
KR102449271B1 (en) | 2012-12-07 | 2022-09-29 | 옥스포드 유니버시티 이노베이션 리미티드 | Droplet assembly by 3D printing |
EP2964201B1 (en) | 2013-03-05 | 2024-02-14 | The Regents of the University of California | Lipid bilayer coated mesoporous silica nanoparticles with a high loading capacity for one or more anticancer agents |
CA3010711A1 (en) | 2016-01-08 | 2017-07-13 | The Regents Of The University Of California | Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery |
CN105603437A (en) * | 2016-01-12 | 2016-05-25 | 北京科技大学 | Low-pH controllable-release intelligent corrosion inhibitor preparation method |
US10894956B2 (en) * | 2017-03-03 | 2021-01-19 | West Virginia University | Phospholipid nanogel for exoglycosidase enzyme stabilization |
GB2561157A (en) * | 2017-03-27 | 2018-10-10 | Univ Oxford Innovation Ltd | Compartmentalised gel matrix and method of production |
CN109942746B (en) * | 2019-03-27 | 2021-03-16 | 浙江理工大学 | Temperature-sensitive photoconductive valve and preparation method thereof |
CN110407980B (en) * | 2019-08-14 | 2021-12-14 | 中国林业科学研究院林产化学工业研究所 | Preparation method of cellulose high-molecular surfactant-based pH and temperature dual-response type composite hydrogel |
CN110655606B (en) * | 2019-10-22 | 2021-12-21 | 南京工程学院 | Method for preparing cationic polyacrylamide by composite photo-initiation |
IT202100002537A1 (en) * | 2021-02-05 | 2022-08-05 | Kyme Nanoimaging Srl | MICROFLUIDIC PROCESS FOR THE PREPARATION OF LIPOSOMAL NANOSTRUCTURES LOADED WITH HYDROGEL |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0070023B1 (en) * | 1981-07-15 | 1987-09-30 | Nippon Oil Co. Ltd. | Process for producing water-insoluble polymers of uniform shape |
US5314811A (en) * | 1992-07-13 | 1994-05-24 | Merck & Co., Inc. | Process for converting lipid-containing bacterial capsular polysaccharide into lipid-free polysaccharide |
US5573934A (en) * | 1992-04-20 | 1996-11-12 | Board Of Regents, The University Of Texas System | Gels for encapsulation of biological materials |
US5464629A (en) * | 1993-11-16 | 1995-11-07 | Georgetown University | Method of forming hydrogel particles having a controlled size using liposomes |
NZ313264A (en) * | 1995-08-01 | 1999-11-29 | Novartis Ag | Liposomal oligonucleotide compositions |
WO1998000170A1 (en) * | 1996-07-01 | 1998-01-08 | Universiteit Utrecht | Hydrolysable hydrogels for controlled release |
US6284375B1 (en) * | 1996-10-18 | 2001-09-04 | Tuo Jin | Lipid vesicle system |
US6018033A (en) * | 1997-05-13 | 2000-01-25 | Purdue Research Foundation | Hydrophilic, hydrophobic, and thermoreversible saccharide gels and forms, and methods for producing same |
EP1146861B1 (en) * | 1999-02-03 | 2005-06-29 | PowderJect Research Limited | Hydrogel particle formulations |
US7943067B2 (en) * | 2001-08-16 | 2011-05-17 | Polytechnic Institute Of New York University | Nanogels and their production using liposomes as reactors |
-
2002
- 2002-08-14 US US10/218,554 patent/US7943067B2/en not_active Expired - Fee Related
- 2002-08-14 US US10/218,553 patent/US7618565B2/en not_active Expired - Fee Related
- 2002-08-15 AT AT02766005T patent/ATE433744T1/en not_active IP Right Cessation
- 2002-08-15 AU AU2002329761A patent/AU2002329761A1/en not_active Abandoned
- 2002-08-15 WO PCT/US2002/026055 patent/WO2003015936A1/en not_active Application Discontinuation
- 2002-08-15 EP EP02766006.7A patent/EP1511580B1/en not_active Expired - Lifetime
- 2002-08-15 DE DE60232666T patent/DE60232666D1/en not_active Expired - Lifetime
- 2002-08-15 WO PCT/US2002/026056 patent/WO2003015701A2/en not_active Application Discontinuation
- 2002-08-15 EP EP02766005A patent/EP1425112B1/en not_active Expired - Lifetime
-
2009
- 2009-11-16 US US12/619,090 patent/US7883648B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1511580B1 (en) | 2015-03-18 |
EP1511580A2 (en) | 2005-03-09 |
US20030044455A1 (en) | 2003-03-06 |
US7618565B2 (en) | 2009-11-17 |
WO2003015701A2 (en) | 2003-02-27 |
EP1511580A4 (en) | 2005-06-08 |
AU2002329761A1 (en) | 2003-03-03 |
ATE433744T1 (en) | 2009-07-15 |
EP1425112A1 (en) | 2004-06-09 |
WO2003015701A3 (en) | 2004-12-29 |
EP1425112B1 (en) | 2009-06-17 |
US20030035842A1 (en) | 2003-02-20 |
US20100062054A1 (en) | 2010-03-11 |
US7943067B2 (en) | 2011-05-17 |
WO2003015936A1 (en) | 2003-02-27 |
EP1425112A4 (en) | 2005-06-15 |
DE60232666D1 (en) | 2009-07-30 |
US7883648B2 (en) | 2011-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7883648B2 (en) | Lipobeads and their production | |
Kazakov et al. | UV-induced gelation on nanometer scale using liposome reactor | |
Volodkin et al. | Coating of negatively charged liposomes by polylysine: Drug release study | |
Liu et al. | Stable polymeric nanoballoons: lyophilization and rehydration of cross-linked liposomes | |
Nardin et al. | Amphiphilic block copolymer nanocontainers as bioreactors | |
CA2388344C (en) | Amphiphilic polymeric vesicles | |
US7217427B2 (en) | Polymersomes and related encapsulating membranes | |
Kazakov et al. | Liposome-nanogel structures for future pharmaceutical applications | |
Brizard et al. | Self-assembly approaches for the construction of cell architecture mimics | |
Petralito et al. | Design and development of PEG-DMA gel-in-liposomes as a new tool for drug delivery | |
Rank et al. | Preparation of monodisperse block copolymer vesicles via a thermotropic cylinder− vesicle transition | |
US20140127287A1 (en) | Liposome-encapsulated hydrogels for use in a drug delivery system | |
Zuraw-Weston et al. | Nanoparticles binding to lipid membranes: from vesicle-based gels to vesicle tubulation and destruction | |
US20080260833A1 (en) | Drug delivery vehicle containing vesicles in a hydrogel base | |
Zhang et al. | Salt-induced fusion of microcapsules of polyelectrolytes | |
Kabanov et al. | What happens to negatively charged lipid vesicles upon interacting with polycation species? | |
Hentze et al. | Templating vesicles, microemulsions, and lyotropic mesophases by organic polymerization processes | |
Li et al. | Hierarchical polyion complex vesicles from PAMAM dendrimers | |
KR101935003B1 (en) | Conjugate showing upper critical solution temperature and temperature-responsive liposome prepared by immobilizing this conjugate on the liposome surface | |
WO2012117587A1 (en) | Method for producing lipid structure | |
Kazakov et al. | Lipobeads as drug delivery systems | |
Park et al. | Selective and vertical microfabrication of lipid tubule arrays on glass substrates using template-guided gentle hydration | |
Cao | AN EXPERIMENTAL STUDY OF LIPID-MEMBRANE BASED STRUCTURE FORMATION AND DEVELOPMENT OF A RESPONSIVE SYSTEM | |
Pepin-Donat et al. | Lipidic composite vesicles based on poly (NIPAM), chitosan or hyaluronan: behaviour under stresses | |
Li | Programmable shape engineering of polymer vesicles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG UZ VC VN YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
COP | Corrected version of pamphlet |
Free format text: PAGES 1/16-16/16, DRAWINGS, REPLACED BY NEW PAGES 1/16-16/16 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002766006 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2002766006 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |